Molecular Biology of Lung Cancer: Clinical Implications

Jill E. Larsen, John D. Minna

Research output: Contribution to journalArticle

119 Citations (Scopus)

Abstract

Lung cancer is a heterogeneous disease clinically, biologically, histologically, and molecularly. Understanding the molecular causes of this heterogeneity, which might reflect changes occurring in different classes of epithelial cells or different molecular changes occurring in the same target lung epithelial cells, is the focus of current research. Identifying the genes and pathways involved, determining how they relate to the biological behavior of lung cancer, and their utility as diagnostic and therapeutic targets are important basic and translational research issues. This article reviews current information on the key molecular steps in lung cancer pathogenesis, their timing, and clinical implications.

Original languageEnglish (US)
Pages (from-to)703-740
Number of pages38
JournalClinics in Chest Medicine
Volume32
Issue number4
DOIs
StatePublished - Dec 2011

Fingerprint

Molecular Biology
Lung Neoplasms
Epithelial Cells
Translational Medical Research
Lung
Research
Genes
Therapeutics

Keywords

  • Gene mutation
  • Genome-wide analysis
  • Lung cancer
  • Lung carcinogenesis

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Molecular Biology of Lung Cancer : Clinical Implications. / Larsen, Jill E.; Minna, John D.

In: Clinics in Chest Medicine, Vol. 32, No. 4, 12.2011, p. 703-740.

Research output: Contribution to journalArticle

@article{3e3c550fa25340358cf0c26b3ae183fd,
title = "Molecular Biology of Lung Cancer: Clinical Implications",
abstract = "Lung cancer is a heterogeneous disease clinically, biologically, histologically, and molecularly. Understanding the molecular causes of this heterogeneity, which might reflect changes occurring in different classes of epithelial cells or different molecular changes occurring in the same target lung epithelial cells, is the focus of current research. Identifying the genes and pathways involved, determining how they relate to the biological behavior of lung cancer, and their utility as diagnostic and therapeutic targets are important basic and translational research issues. This article reviews current information on the key molecular steps in lung cancer pathogenesis, their timing, and clinical implications.",
keywords = "Gene mutation, Genome-wide analysis, Lung cancer, Lung carcinogenesis",
author = "Larsen, {Jill E.} and Minna, {John D.}",
year = "2011",
month = "12",
doi = "10.1016/j.ccm.2011.08.003",
language = "English (US)",
volume = "32",
pages = "703--740",
journal = "Clinics in Chest Medicine",
issn = "0272-5231",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Molecular Biology of Lung Cancer

T2 - Clinical Implications

AU - Larsen, Jill E.

AU - Minna, John D.

PY - 2011/12

Y1 - 2011/12

N2 - Lung cancer is a heterogeneous disease clinically, biologically, histologically, and molecularly. Understanding the molecular causes of this heterogeneity, which might reflect changes occurring in different classes of epithelial cells or different molecular changes occurring in the same target lung epithelial cells, is the focus of current research. Identifying the genes and pathways involved, determining how they relate to the biological behavior of lung cancer, and their utility as diagnostic and therapeutic targets are important basic and translational research issues. This article reviews current information on the key molecular steps in lung cancer pathogenesis, their timing, and clinical implications.

AB - Lung cancer is a heterogeneous disease clinically, biologically, histologically, and molecularly. Understanding the molecular causes of this heterogeneity, which might reflect changes occurring in different classes of epithelial cells or different molecular changes occurring in the same target lung epithelial cells, is the focus of current research. Identifying the genes and pathways involved, determining how they relate to the biological behavior of lung cancer, and their utility as diagnostic and therapeutic targets are important basic and translational research issues. This article reviews current information on the key molecular steps in lung cancer pathogenesis, their timing, and clinical implications.

KW - Gene mutation

KW - Genome-wide analysis

KW - Lung cancer

KW - Lung carcinogenesis

UR - http://www.scopus.com/inward/record.url?scp=80555134650&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80555134650&partnerID=8YFLogxK

U2 - 10.1016/j.ccm.2011.08.003

DO - 10.1016/j.ccm.2011.08.003

M3 - Article

C2 - 22054881

AN - SCOPUS:80555134650

VL - 32

SP - 703

EP - 740

JO - Clinics in Chest Medicine

JF - Clinics in Chest Medicine

SN - 0272-5231

IS - 4

ER -